Top
ABLIM2 has not been detected as a mutational cancer driver

ABLIM2
Ensembl id ENSG00000163995
Mutated samples
Coding Sequence 47 (0.7%)
Protein Affecting 27 (0.4%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all ABLIM2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 10 6 1.63
Pancreas adenocarcinoma No 3 3 1.40
Uterine corpus endometrioid carcinoma No 5 3 1.30
Head and neck squamous cell carcinoma No 4 3 0.80
Lung adenocarcinoma No 2 2 0.51
Lung squamous cell carcinoma No 3 2 1.15
Chronic lymphocytic leukemia No 4 2 0.69
Esophageal carcinoma No 2 2 1.37
Bladder carcinoma No 2 1 1.02
Breast carcinoma No 4 1 0.09
Stomach adenocarcinoma No 3 1 0.62
Colorectal adenocarcinoma No 1 1 0.44
Hepatocarcinoma No 1 0 0.00
Medulloblastoma No 2 0 0.00
Glioblastoma multiforme No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence